診断用酵素の市場規模、シェア、動向分析レポート：タイプ別、用途別、製品別、最終用途別、地域別、セグメント別予測、2025年～2030年

診断用酵素市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の診断用酵素市場規模は2025年から2030年にかけてCAGR 7.1％を記録し、2030年には77億1,000万米ドルに達すると予測されています。

診断用酵素市場の成長は、病理学に広く応用される診断用酵素に対する需要の高まりに起因しています。さらに、ウイルス感染の診断技術の進歩が市場成長を促進すると予測されています。

診断用酵素は、酵素活性によって提供される高い感度と精度によって広く採用されています。酵素活性は、臨床症状やその他の診断指標よりも早く検出される可能性があります。バイオセンサーは、医療診断、病原体検出、モニタリングのためのツールとして普及しています。バイオセンサーは、精度、感度、選択性、そして日常的に使用できる迅速な検出戦略により人気を博しています。酵素の血清レベルの診断は、細胞間成分の血流への放出をもたらす細胞損傷の指標として用いられてきました。

呼吸器のウイルス感染症は、ヒトの最も一般的な疾患の一つであり、COVID-19のような新興ウイルスの発生によって引き起こされる感染症は、公衆衛生に脅威をもたらしています。したがって、このような流行の発生を阻止し、抗生物質の不必要な使用を防ぐためには、ウイルス病原体の検出が不可欠です。そのため、新しい診断戦略が主要プレーヤーによって採用されています。LightMix（Roche Molecular Diagnostics、スイス）、AccuPower（Bioneer、韓国）、PowerChek（Kogene Biotech、韓国）、Anyplex（Seegene、韓国）、UltraFast kits（Nanobiosys、韓国）、DiaPlexQ（SolGent、韓国）は、MERS-CoV RNA検出用の市販のRT-PCRキットの一部で、99.03％という高い感度を有しています。

診断用酵素検査の数が増えたことで、その性能に関する多くの論文が発表され、推奨やガイドラインが増加しました。さらに、償還経路には明確なガイドラインや体系的な医療技術評価（HTA）が欠如しています。診断用酵素検査に対する支払者の意思決定に影響を与える様々な要因には、FDAの認可、医師の支持と臨床ガイドライン、競合他社の保険適用方針、コスト／便益分析、HTAの結果、雇用者や支持団体の要求などがあります。

さらに、この市場で事業を展開する主要企業は、幅広い用途に使用できる製品の拡大と上市に注力しています。例えば、2022年3月、メリディアン・バイオサイエンス社は、非侵襲的リキッドバイオプシーに使用できる2種類のマスターミックスを発売しました。このような画期的な技術の発売により、精製核酸からの従来のqPCRと比較して、より優れた性能レベルの分析が可能になります。

診断用酵素市場レポートハイライト

• グルコースオキシダーゼ/デヒドロゲナーゼ分野は2024年に9.3%の最大収益シェアを占めました。グルコースオキシダーゼ（GOx）は、主にグルコースモニタリングにおける重要な役割と、様々な生物医学分野での用途の増加により、高い需要があります。
• 乳酸デヒドロゲナーゼ（LDH）セグメントは、糖尿病管理のための分子デバイスの採用が増加していることが主な要因となって、予測期間を通じて大幅な成長が見込まれています。
• 感染症分野は2024年に36.0％の最大市場シェアを占めました。PCR技術の広範な応用により、感染症の早期特定と治療が著しく進歩しました。
• 腫瘍学セグメントは予測期間中CAGR 8.8％で成長する見込みです。
• 臨床酵素セグメントは、2024年に65.3％の最大の収益シェアを占めました。
• 臨床検査室セグメントは2024年に48.2%の最大市場シェアを占めました。このセグメントの成長は複数の要因によって牽引されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 診断用酵素市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
• 診断用酵素市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 診断用酵素市場：タイプ推定・動向分析

• セグメントダッシュボード
• 診断用酵素市場：タイプ変動分析
• 診断用酵素市場のタイプ別展望
• 2018年から2030年までの市場規模と予測および動向分析
• Taqポリメラーゼ
• MMLV RT
• HIV RT
• ホットスタートタックポル
• UNG
• RNase阻害剤
• Bstポリメラーゼ（LAMP酵素）
• PCRマスターミックス
• 凍結乾燥ポリメラーゼ
• T7 RNAポリメラーゼ
• Cas9酵素
• 酸性ホスファターゼ
• アラニンアミノトランスフェラーゼ
• アルカリホスファターゼ
• アミラーゼ
• アンジオテンシン変換酵素
• アスパラギン酸アミノトランスフェラーゼ
• コリンエステラーゼ
• クレアチニンキナーゼ
• ガンマグルタミルトランスフェラーゼ
• 乳酸脱水素酵素
• レニン
• グルコースオキシダーゼ/グルコースデヒドロゲナーゼ
• ウレアーゼ
• 乳酸オキシダーゼ
• 過酸化ホースラディッシュ
• グルタミン酸オキシダーゼ
• その他

第5章 診断用酵素市場：用途推定・動向分析

• セグメントダッシュボード
• 診断用酵素市場：用途変動分析
• 診断用酵素市場の用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 糖尿病
• 腫瘍学
• 心臓病学
• 感染症
• 腎臓学
• 自己免疫疾患
• その他

第6章 診断用酵素市場：製品推定・動向分析

• セグメントダッシュボード
• 診断用酵素市場：製品変動分析
• 診断用酵素市場の製品別見通し
• 2018年から2030年までの市場規模と予測および動向分析
• 分子酵素
• 臨床酵素

第7章 診断用酵素市場：最終用途推定・動向分析

• セグメントダッシュボード
• 診断用酵素市場：最終用途変動分析
• 最終用途別診断用酵素市場展望
• 2018年から2030年までの市場規模と予測および動向分析
• 病院
• 臨床検査室
• その他

第8章 診断用酵素市場：地域推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 市場参入企業の分類
• 主要市場参入企業による最近の動向と影響分析
• 企業市場シェア分析、2024年
• 主要企業プロファイル
  • Takara Bio, Inc.
  • Promega Corporation
  • Enzo Biochem Inc
  • Merck KGaA
  • Thermo Fisher Scientific, Inc
  • Creative Enzymes
  • F. Hoffmann-La Roche Ltd.
  • Solis BioDyne
  • Ambliqon A/S.
  • Yashraj Biotechnology Ltd.

List of Tables

• Table 1. List of abbreviation
• Table 2. North America Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
• Table 3. North America Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 4. North America Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 5. North America Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 6. North America Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 7. U.S. Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 8. U.S. Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 9. U.S. Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 10. U.S. Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 11. Canada Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 12. Canada Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 13. Canada Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 14. Canada Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 15. Mexico Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 16. Mexico Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 17. Mexico Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 18. Mexico Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 19. Europe Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
• Table 20. Europe Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 21. Europe Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 22. Europe Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 23. Europe Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 24. Germany Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 25. Germany Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 26. Germany Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 27. Germany Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 28. UK Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 29. UK Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 30. UK Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 31. UK Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 32. France Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 33. France Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 34. France Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 35. France Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 36. Italy Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 37. Italy Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 38. Italy Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 39. Italy Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 40. Spain Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 41. Spain Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 42. Spain Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 43. Spain Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 44. Denmark Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 45. Denmark Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 46. Denmark Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 47. Denmark Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 48. Sweden Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 49. Sweden Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 50. Sweden Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 51. Sweden Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 52. Norway Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 53. Norway Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 54. Norway Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 55. Norway Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 56. Asia Pacific Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
• Table 57. Asia Pacific Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 58. Asia Pacific Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 59. Asia Pacific Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 60. Asia Pacific Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 61. China Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 62. China Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 63. China Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 64. China Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 65. Japan Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 66. Japan Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 67. Japan Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 68. Japan Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 69. India Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 70. India Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 71. India Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 72. India Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 73. South Korea Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 74. South Korea Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 75. South Korea Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 76. South Korea Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 77. Australia Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 78. Australia Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 79. Australia Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 80. Australia Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 81. Thailand Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 82. Thailand Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 83. Thailand Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 84. Thailand Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 85. Latin America Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
• Table 86. Latin America Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 87. Latin America Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 88. Latin America Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 89. Latin America Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 90. Brazil Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 91. Brazil Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 92. Brazil Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 93. Brazil Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 94. Argentina Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 95. Argentina Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 96. Argentina Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 97. Argentina Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 98. MEA Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
• Table 99. MEA Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 100. MEA Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 101. MEA Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 102. MEA Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 103. South Africa Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 104. South Africa Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 105. South Africa Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 106. South Africa Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 107. Saudi Arabia Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 108. Saudi Arabia Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 109. Saudi Arabia Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 110. Saudi Arabia Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 111. UAE Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 112. UAE Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 113. UAE Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 114. UAE Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
• Table 115. Kuwait Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
• Table 116. Kuwait Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
• Table 117. Kuwait Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
• Table 118. Kuwait Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1. Market research process
• Fig. 2. Data triangulation techniques
• Fig. 3. Primary research pattern
• Fig. 4. Primary interviews in North America
• Fig. 5. Primary interviews in Europe
• Fig. 6. Primary interviews in APAC
• Fig. 7. Primary interviews in Latin America
• Fig. 8. Primary interviews in MEA
• Fig. 9. Market research approaches
• Fig. 10. Value-chain-based sizing & forecasting
• Fig. 11. QFD modeling for market share assessment
• Fig. 12. Market formulation & validation
• Fig. 13. Diagnostic Enzymes market: market outlook
• Fig. 14. Diagnostic Enzymes competitive insights
• Fig. 15. Parent market outlook
• Fig. 16. Related/ancillary market outlook
• Fig. 17. Diagnostic Enzymes market driver impact
• Fig. 18. Diagnostic Enzymes market restraint impact
• Fig. 19. Diagnostic Enzymes market: Type movement analysis
• Fig. 20. Diagnostic Enzymes market: Type outlook and key takeaways
• Fig. 21. Taq polymerase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22. MMLV-RT market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23. HIV RT market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24. Hot start Taq pol market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25. UNG market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26. RNase inhibitor market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27. Bst polymerase (LAMP enzyme) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28. PCR Master Mix market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29. Lyophilised Polymerase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30. T7 RNA polymerase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31. Cas9 enzyme market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32. Acid phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33. Alanine aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34. Alkaline phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35. Amylase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36. Angiotensin converting enzyme market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37. Aspartate aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38. Cholinesterase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39. Creatinine kinase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40. Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41. Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42. Renin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43. Glucose oxidase/glucose dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44. Urease market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45. Lactate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46. Horseradish peroxidase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47. Glutamate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48. Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 49. Diagnostic Enzymes market: Application movement analysis
• Fig. 50. Diagnostic Enzymes market: Application outlook and key takeaways
• Fig. 51. Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52. Oncology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53. Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54. Infectious Diseases market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55. Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56. Autoimmune Diseases market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57. Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58. Diagnostic Enzymes market: Product movement analysis
• Fig. 59. Diagnostic Enzymes market: Product outlook and key takeaways
• Fig. 60. Molecular Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61. Clinical Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62. Diagnostic Enzymes market: End Use movement analysis
• Fig. 63. Diagnostic Enzymes market: End Use outlook and key takeaways
• Fig. 64. Hospital market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65. Clinical Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66. Other End Users market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67. Global Diagnostic Enzymes market: Regional movement analysis
• Fig. 68. Global Diagnostic Enzymes market: Regional outlook and key takeaways
• Fig. 69. Global Diagnostic Enzymes market share and leading players
• Fig. 70. North America, by country
• Fig. 71. North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72. U.S. key country dynamics
• Fig. 73. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74. Canada key country dynamics
• Fig. 75. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76. Mexico key country dynamics
• Fig. 77. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79. UK key country dynamics
• Fig. 80. UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81. Germany key country dynamics
• Fig. 82. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83. France key country dynamics
• Fig. 84. France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85. Italy key country dynamics
• Fig. 86. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87. Spain key country dynamics
• Fig. 88. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89. Denmark key country dynamics
• Fig. 90. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 91. Sweden key country dynamics
• Fig. 92. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 93. Norway key country dynamics
• Fig. 94. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 95. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96. China key country dynamics
• Fig. 97. China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98. Japan key country dynamics
• Fig. 99. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 100. India key country dynamics
• Fig. 101. India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 102. Thailand key country dynamics
• Fig. 103. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 104. South Korea key country dynamics
• Fig. 105. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 106. Australia key country dynamics
• Fig. 107. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 108. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 109. Brazil key country dynamics
• Fig. 110. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 111. Argentina key country dynamics
• Fig. 112. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 113. Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 114. South Africa key country dynamics
• Fig. 115. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 116. Saudi Arabia key country dynamics
• Fig. 117. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 118. UAE key country dynamics

Diagnostic Enzymes Market Growth & Trends:

The global diagnostic enzymes market size is expected to reach USD 7.71 billion by 2030, registering a CAGR of 7.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growth of the diagnostic enzymes market is attributed to rising demand for the enzymes in diagnostics with wide applications in pathology. Moreover, advancements in diagnostic techniques for viral infection are anticipated to propel the market growth.

Diagnostic enzymes are widely adopted owing to the higher sensitivity and accuracy offered by enzyme activity. The enzyme activities can be earlier than clinical signs and other diagnostic indicators. Biosensors are becoming a popular potential tool for medical diagnostics, pathogen detection, and monitoring. Biosensors have gained popularity owing to the accuracy, sensitivity, selectivity, and rapid detection strategies that can be used routinely. Diagnosis of serum levels of the enzymes has been used as an indicator of the cellular damage that results in the release of the intercellular components into the bloodstream.

Viral infections of the respiratory tract are among the most common disorders in humans, and the ones caused due to the outbreak of emerging viruses, such as COVID-19, have posed a threat to public health. Therefore, detection of the viral pathogens is vital to stop the occurrence of such epidemics and prevent the unnecessary use of antibiotics. Therefore, novel diagnostic strategies have been adopted by the key players. LightMix (Roche Molecular Diagnostics, Switzerland), AccuPower (Bioneer, Korea), PowerChek (Kogene Biotech, Korea), Anyplex (Seegene, Korea), UltraFast kits (Nanobiosys, Korea), and DiaPlexQ (SolGent, Korea) are some of the commercially available RT-PCR kits for MERS-CoV RNA detection with sensitivities as high as 99.03%.

An increase in the number of diagnostic enzyme tests has led to a boost in recommendations and guidelines with a number of publications on their performance. Moreover, reimbursement pathways lack clear guidelines and systematic Health Technology Assessment (HTA). Various factors influencing payer decisions for diagnostic enzyme tests include FDA clearance, physician support & clinical guidelines, competitor coverage policies, cost/benefit analyses, results of HTAs, and employer or advocacy group demands.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in March 2022, Meridian Bioscience, Inc. launched two master mixes, which can be used in non-invasive liquid biopsy. The launch of such breakthrough technologies enables better analysis of the performance levels as compared to traditional qPCR from the purified nucleic acid.

Diagnostic Enzymes Market Report Highlights:

• The glucose oxidase/dehydrogenase segment accounted for the largest revenue share of 9.3% in 2024. Glucose oxidase (GOx) is in high demand primarily due to its essential role in glucose monitoring and its increasing applications in various biomedical fields.
• The lactate dehydrogenase (LDH) segment is anticipated to experience substantial growth throughout the forecast period, largely driven by the rising adoption of molecular devices for diabetes management.
• The infectious diseases segment held the largest market share of 36.0% in 2024. The widespread application of PCR technology has significantly advanced the early identification and treatment of infectious diseases.
• The oncology segment is expected to grow at a CAGR of 8.8% over the forecast period.
• The clinical enzyme segment accounted for the largest revenue share of 65.3% in 2024, largely due to the increasing application of enzymes in clinical chemistry.
• The clinical laboratories segment held the largest market share of 48.2% in 2024. The segment growth is driven by multiple factors.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. Application
  • 1.2.4. End Use
  • 1.2.5. Regional Scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Diagnostic Enzymes Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rise in the demand for enzymes in pathology
    • 3.2.1.2. Advancements in diagnostic testing of viral infection
    • 3.2.1.3. Increase in the demand for Point-of-Care testing
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of enzyme-based diagnostic tests
    • 3.2.2.2. Regulatory & reimbursement hurdles for enzyme diagnostics
• 3.3. Diagnostic Enzymes Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Diagnostic Enzymes Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Diagnostic Enzymes Market: Type Movement Analysis
• 4.3. Diagnostic Enzymes Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Taq Polymerase
  • 4.5.1. Taq Polymerase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. MMLV RT
  • 4.6.1. MMLV RT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. HIV RT
  • 4.7.1. HIV RT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Hot Start Taq Pol
  • 4.8.1. Hot Start Taq Pol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. UNG
  • 4.9.1. UNG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.10. Rnase Inhibitors
  • 4.10.1. Rnase Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.11. Bst Polymerase (LAMP ENZYME)
  • 4.11.1. Bst Polymerase (LAMP ENZYME) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.12. PCR Master Mix
  • 4.12.1. PCR Master Mix Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.13. Lyophilized Polymerase
  • 4.13.1. Lyophilized Polymerase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.14. T7 Rna Polymerase
  • 4.14.1. T7 Rna Polymerase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.15. Cas9 Enzyme
  • 4.15.1. Cas9 Enzyme Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.16. Acid Phosphatase
  • 4.16.1. Acid Phosphatase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.17. Alanine Aminotransferase
  • 4.17.1. Alanine Aminotransferase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.18. Alkaline Phosphatase
  • 4.18.1. Alkaline Phosphatase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.19. Amylase
  • 4.19.1. Amylase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.20. Angiotensin Converting Enzyme
  • 4.20.1. Angiotensin Converting Enzyme Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.21. Aspartate Aminotransferase
  • 4.21.1. Aspartate Aminotransferase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.22. Cholinesterase
  • 4.22.1. Cholinesterase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.23. Creatinine Kinase
  • 4.23.1. Creatinine Kinase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.24. Gamma Glutamyl Transferase
  • 4.24.1. Gamma Glutamyl Transferase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.25. Lactate Dehydrogenase
  • 4.25.1. Lactate Dehydrogenase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.26. Renin
  • 4.26.1. Renin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.27. Glucose Oxidase/Glucose Dehydrogenase
  • 4.27.1. Glucose Oxidase/Glucose Dehydrogenase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.28. Urease
  • 4.28.1. Urease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.29. Lactate Oxidase
  • 4.29.1. Lactate Oxidase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.30. Horseradish Peroxide
  • 4.30.1. Horseradish Peroxide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.31. Glutamate Oxidase
  • 4.31.1. Glutamate Oxidase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.32. Others
  • 4.32.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Diagnostic Enzymes Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Diagnostic Enzymes Market: Application Movement Analysis
• 5.3. Diagnostic Enzymes Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Diabetes
  • 5.5.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Oncology
  • 5.6.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Cardiology
  • 5.7.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Infectious Disease
  • 5.8.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Nephrology
  • 5.9.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.10. Autoimmune Diseases
  • 5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.11. Others
  • 5.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Diagnostic Enzymes Market: Product Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Diagnostic Enzymes Market: Product Movement Analysis
• 6.3. Diagnostic Enzymes Market by Product Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Molecular Enzymes
  • 6.5.1. Molecular Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Clinical Enzymes
  • 6.6.1. Clinical Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Diagnostic Enzymes Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Diagnostic Enzymes Market: End Use Movement Analysis
• 7.3. Diagnostic Enzymes Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Hospital
  • 7.5.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Clinical Laboratories
  • 7.6.1. Clinical Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Diagnostic Enzymes Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Recent Developments & Impact Analysis by Key Market Participants
• 9.3. Company Market Share Analysis, 2024
• 9.4. Key Company Profiles
  • 9.4.1. Takara Bio, Inc.
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Promega Corporation
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Enzo Biochem Inc
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Merck KGaA
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Thermo Fisher Scientific, Inc
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Creative Enzymes
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. F. Hoffmann-La Roche Ltd.
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Solis BioDyne
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Ambliqon A/S.
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Yashraj Biotechnology Ltd.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives